[YMAB] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[YMAB] Y-mAbs Therapeutics, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 18.72%
YoY- -37.25%
Quarter Report
YMAB's Result
YMAB's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 20,454 12,537 8,965 0 0 0 0 -
PBT -7,560 -27,526 -28,858 -32,832 -23,922 -11,426 -3,827 12.00%
Tax 187 1,509 0 0 0 0 -3,842 -
NP -7,747 -29,035 -28,858 -32,832 -23,922 -11,426 -3,827 12.46%
Tax Rate - - - - - - - -
Total Cost 28,201 41,572 37,823 32,832 23,922 11,426 3,827 39.47%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -37.88 -231.59 -321.90 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -0.18 -0.66 -0.66 -0.82 -0.70 -0.42 -0.11 8.55%
EPS Diluted -0.18 -0.66 -0.66 -0.82 -0.70 -0.42 -0.11 8.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.